Sökning: "Cardiac hypertrophy"
Visar resultat 6 - 10 av 51 avhandlingar innehållade orden Cardiac hypertrophy.
6. Cardiac abnormalities in chronic kidney disease
Sammanfattning : Chronic kidney disease (CKD) is a global health problem associated with increased risk of mortality and development of end-stage renal disease (ESRD). Cardiovascular diseases are the leading cause of morbidity and mortality even before the development of ESRD. LÄS MER
7. Cardiac function and long-term volume load : Physiological investigations in endurance athletes and in patients operated on for aortic regurgitation
Sammanfattning : Background and aims. The heart is a remarkably adaptable organ, continuously changing its output to match metabolic demands and haemodynamic load. But also in long-term settings, such as in chronic or repeated volume load, there are changes in cardiac dimensions and mass termed cardiac hypertrophy. LÄS MER
8. An epidemiological perspective on heart and lung weight in cardiac and intoxication deaths
Sammanfattning : The main purpose of a medico-legal autopsy is to determine the cause and manner of death. A forensic pathologist makes assessments of this using several sources of information, one of which is the discrepancy between measured organ weight and reference values. LÄS MER
9. Cardiac lipids and their role in the diseased heart
Sammanfattning : Lipids play an essential role within the heart as they are involved in energy storage, membrane stability and signaling. Changes in cardiac lipid composition and utilization may thus have profound effects on cardiac function. Importantly, the diseased heart is associated with intracellular metabolic abnormalities, including accumulation of lipids. LÄS MER
10. The endocrine heart - metabolic actions of atrial natriuretic peptide
Sammanfattning : Abstract The natriuretic peptides (NPs), namely atrial natriuretic peptide (ANP) and bran natriuretic peptide (BNP), which are secreted from cardiomyocytes in response to cardiac wall stress, play a significant role in the regulation of blood pressure, intravascular volume, and cardiac remodeling. Recently, NPs emerged as hormones with metabolic actions such as inhibition of the renin-angiotensin system and inhibition of inflammation, together with lipolysis and adipose tissue browning. LÄS MER